Ocular Therapeutix (OCUL) Current Leases (2019 - 2025)
Historic Current Leases for Ocular Therapeutix (OCUL) over the last 7 years, with Q4 2025 value amounting to $2.8 million.
- Ocular Therapeutix's Current Leases rose 4573.2% to $2.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 million, marking a year-over-year increase of 4573.2%. This contributed to the annual value of $2.8 million for FY2025, which is 4573.2% up from last year.
- As of Q4 2025, Ocular Therapeutix's Current Leases stood at $2.8 million, which was up 4573.2% from $2.8 million recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Current Leases registered a high of $2.8 million during Q4 2025, and its lowest value of $1.4 million during Q1 2021.
- Over the past 5 years, Ocular Therapeutix's median Current Leases value was $1.7 million (recorded in 2023), while the average stood at $1.9 million.
- Per our database at Business Quant, Ocular Therapeutix's Current Leases tumbled by 1518.15% in 2024 and then soared by 6086.2% in 2025.
- Over the past 5 years, Ocular Therapeutix's Current Leases (Quarter) stood at $1.6 million in 2021, then fell by 1.54% to $1.6 million in 2022, then fell by 0.81% to $1.6 million in 2023, then grew by 21.88% to $1.9 million in 2024, then surged by 45.73% to $2.8 million in 2025.
- Its Current Leases was $2.8 million in Q4 2025, compared to $2.8 million in Q3 2025 and $2.6 million in Q2 2025.